Table. 6.

Logistic regression examining the association of mortality and survival between surgical approaches

Outcome OR (95% CI) p-value AOR (95% CI)a) p-value a)
30-day mortality
Open Ref Ref Ref Ref
Minimally-invasive 0.90 (0.67, 1.20) 0.469 1.00 (0.73, 1.36) 0.985
Converted to open 1.18 (0.77, 1.81) 0.455 1.07 (0.68, 1.70) 0.769
90-day mortality
Open Ref Ref Ref Ref
Minimally-invasive 0.88 (0.72, 1.09) 0.252 0.99 (0.79, 1.22) 0.897
Converted to open 1.19 (0.88, 1.61) 0.264 1.09 (0.79, 1.51) 0.593
Long-term survival
Open Ref Ref Ref Ref
Minimally-invasive 1.42 (1.28, 1.57) < 0.001* 1.40 (1.25, 1.56) < 0.001*
Converted to open 1.22 (1.02, 1.46) 0.028* 1.24 (1.04, 1.49) 0.020*

OR, odds ratio; AOR, adjusted odds ratio; CI, confidence interval.

a)Estimates based on adjusted models adjusting for age, gender, race, insurance status, treatment facility type, Charlson-Deyo comorbidity score, CA 19-9 tumor marker, tumor size, and case-volume per year quartiles.

*Statistical significance at p < 0.05.

Ann Hepatobiliary Pancreat Surg 2023;27:292-300 https://doi.org/10.14701/ahbps.22-101
© 2023 Ann Hepatobiliary Pancreat Surg